Nikko Asset Management Americas’s Inovio Pharmaceuticals INO Stock Holding History

Nikko Asset Management Americas’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-48,638	Closed	-$13.9M	–	212
2020 Q2	$13.9M	Sell	48,638 -177,527	-78%	-$28.5M	0.18%	74
2020 Q1	$20.2M	Sell	226,165 -194,469	-46%	-$12M	0.38%	66
2019 Q4	$16.7M	Sell	420,634 -9,062	-2%	-$273K	0.26%	75
2019 Q3	$10.6M	Buy	429,696 +22,688	+6%	+$690K	0.19%	92
2019 Q2	$14.4M	Buy	407,008 +135,131	+50%	+$5.37M	0.28%	75
2019 Q1	$12.2M	Buy	+271,877	New	+$13.7M	0.32%	59

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nikko Asset Management Americas's INO Position: Q3 2020 in Review

Nikko Asset Management Americas sold out of Inovio Pharmaceuticals (INO) in Q3 2020, closing a stake of 48,638 shares — an estimated $13.9M sold.

Nikko Asset Management Americas first reported a position in INO in Q1 2019 and held it in 6 quarters. The position peaked at $20.2M in Q1 2020. 212 funds tracked by Wall St. Rank hold INO as of Q3 2020.

Nikko Asset Management Americas reported no remaining Inovio Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Nikko Asset Management Americas sold 48,638 Inovio Pharmaceuticals shares in Q3 2020, an estimated $13.9M.
Nikko Asset Management Americas first reported a position in Inovio Pharmaceuticals in Q1 2019 and held it in 6 quarters.
Nikko Asset Management Americas's Inovio Pharmaceuticals position peaked at $20.2M in Q1 2020.
212 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2020.

Based on Nikko Asset Management Americas's 13F filing for Q3 2020, filed 2 Nov 2020.